IGFBP3 and neoplasm: In this study, we present findings consistent with the “IGFBP3 resistance” model, in which tumor cells acquire higher expression levels of IGFBP3 as well as insensitivity to its inhibitory effects as they become more malignant, as shown in Figure 2A and 2B.